Anti-neurochondrin antibodies are associated with primary autoimmune cerebellar ataxia
Nov. 8, 2022
Researchers from Bern University Hospital and University of Bern presented data from a case study that identified the presence of anti-neurochondrin antibodies as a potential biomarker of primary autoimmune cerebellar ataxia (PACA).